Gregor Diagnostics LLC is a Madison-based company that is dedicated to developing a better screening test for prostate cancer. Their mission is to have a positive impact on the lives of patients, physicians, partners, and employees by striving to make an impact on lives that can be saved. They are innovating together to build a screening test that can accurately determine the aggressiveness of prostate cancer using seminal fluid as a sample source, which allows for direct access to abundant prostate cancer biomarkers.
With over 250,000 times more biomarkers in seminal fluid than in blood serum, Gregor Diagnostics leverages a diverse biomarker panel, including Methylated DNA, proteins, and microparticles, to detect and discriminate between indolent and aggressive prostate cancer. Their proprietary system ensures sample stability, allowing for easy collection in the comfort of one's own home and shipping back to their laboratory. By developing a more accessible and affordable screening test, Gregor Diagnostics aims to help more men get tested and reduce the overdiagnosis and overtreatment of prostate cancer.
Generated from the website